We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+0.62%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$458B
AUM Growth
-$4.68B
Cap. Flow
-$1.4B
Cap. Flow %
-0.31%
Top 10 Hldgs %
13.02%
Holding
2,614
New
88
Increased
949
Reduced
837
Closed
73

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$2.42B
2
WYNN icon
Wynn Resorts
WYNN
+$992M
3
LLY icon
Eli Lilly
LLY
+$964M
4
V icon
Visa
V
+$700M
5
AAL icon
American Airlines Group
AAL
+$626M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$1.24B
2
DLTR icon
Dollar Tree
DLTR
+$1.13B
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$1.03B
4
GILD icon
Gilead Sciences
GILD
+$792M
5
ROC
ROCKWOOD HLDGS INC
ROC
+$788M

Sector Composition

Rank Sector Weight
1 Healthcare 18.45%
2 Consumer Discretionary 13.78%
3 Financials 12.98%
4 Industrials 11.9%
5 Technology 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNIS
2501
DELISTED
Unilife Corporation
UNIS
$55K ﹤0.01%
2,410
– –
NAVB
2502
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$53K ﹤0.01%
2,000
– –
EPAX
2503
DELISTED
Ambassadors Group Inc
EPAX
$53K ﹤0.01%
14,300
– –
SYPR icon
2504
Sypris Solutions
SYPR
$46.9M
$52K ﹤0.01%
15,700
– –
IDXG
2505
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$49K ﹤0.01%
204
– –
ACHV icon
2506
Achieve Life Sciences
ACHV
$687M
$47K ﹤0.01%
8
– –
DNDN
2507
DELISTED
DENDREON CORPORATION
DNDN
$46K ﹤0.01%
31,700
– –
CNSY
2508
Cerenome, Inc. Common Stock
CNSY
$25.5M
– –
0
– –
BIOL
2509
DELISTED
Biolase, Inc.
BIOL
$43K ﹤0.01%
1
– –
BXC icon
2510
BlueLinx
BXC
$701M
$36K ﹤0.01%
2,724
+1,250
+85% +$15.8K
ESCR
2511
DELISTED
ESCALERA RESOURCES CO
ESCR
$35K ﹤0.01%
18,613
+4,100
+28% +$8.88K
IMN
2512
DELISTED
Imation
IMN
$34K ﹤0.01%
+11,400
New +$36.3K
FXEN
2513
DELISTED
FX ENERGY INC
FXEN
$33K ﹤0.01%
+11,000
New +$35.3K
FPP.WS
2514
DELISTED
FieldPoint Petroleum Corporation Common Stock Purchase Warrants
FPP.WS
$32K ﹤0.01%
46,200
– –
LTRE
2515
DELISTED
LEARNING TREE INTL INC
LTRE
$29K ﹤0.01%
12,550
– –
WTSL
2516
DELISTED
WET SEAL INC CL-A
WTSL
$26K ﹤0.01%
48,775
– –
OMEX icon
2517
Odyssey Marine Exploration
OMEX
$49.8M
$25K ﹤0.01%
2,333
+666
+40% +$9.71K
GVP
2518
DELISTED
GSE Systems, Inc.
GVP
$24K ﹤0.01%
1,530
– –
ATLC icon
2519
Atlanticus Holdings
ATLC
$1.48B
$21K ﹤0.01%
11,094
-1,320
-11% -$3.44K
YTEN
2520
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
– –
0
– –
GMO
2521
DELISTED
General Moly, Inc.
GMO
$17K ﹤0.01%
22,800
+8,000
+54% +$7.83K
BAXS
2522
DELISTED
BAXANO SURGICAL INC COM STK (DE)
BAXS
$5K ﹤0.01%
25,731
-4,000
-13% -$1.64K
END
2523
DELISTED
ENDEAVOUR INTERNATIONAL CORP NEW (NV)
END
$3K ﹤0.01%
10,428
– –
CYHHZ
2524
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$2K ﹤0.01%
73,700
– –
AGIO icon
2525
Agios Pharmaceuticals
AGIO
$2.04B
– –
-1,019,913
Closed -$46.7M
99 100
101
102 103

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates's Q3 2014 Portfolio in Review

As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
  • T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
  • T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
  • T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
  • T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.

Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.